Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00999661 · ClinicalTrials.gov registry record
A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C
A clinical trial, sponsored by Ethicon Endo-Surgery.
- Completed
- Registry status
- 231
- Enrollment target
NCT00999661: Completed study, sponsored by Ethicon Endo-Surgery.
NCT00999661 is a clinical trial that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 231 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00999661 has completed, sponsored by Ethicon Endo-Surgery.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the results patients are obtaining with the Realize™ Adjustable Gastric Band-C during the first 24 months after surgery.
Primary Outcome
Percent excess weight change from baseline to 24 months was calculated as (the baseline weight minus the weight at 24 months) divided by the (baseline weight minus the ideal body weight (using the upper limit of the midpoint range in the Metropolitan Tables for Life Insurance, 1983) x 100). Last observation carried forward was used for early terminated subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-05 |
What the finished NCT00999661 record still lists
NCT00999661 is an observational study that tracks outcomes without assigning an intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00999661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00999661 about?
NCT00999661 is a clinical study titled "A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C". The purpose of this study is to evaluate the results patients are obtaining with the Realize™ Adjustable Gastric Band-C during the first 24 months after surgery.
What is the current status of trial NCT00999661?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2009-11. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT00999661?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia